Ahmad Yusuf, Funaki Brian, Jilani Sana, Ahmed Osman
Lake Erie College of Osteopathic Medicine, Erie, Pennsylvania.
Department of Radiology, Section of Vascular and Interventional Radiology, University of Chicago Medicine, Chicago, Illinois.
J Vasc Interv Radiol. 2022 Nov;33(11):1295-1300.e6. doi: 10.1016/j.jvir.2022.07.010. Epub 2022 Jul 19.
To identify and analyze all medical malpractice and product liability lawsuits pertaining to inferior vena cava (IVC) filters published within a well-recognized legal research database.
LexisNexis, a legal research database, was used to retrieve cases that mentioned harm from IVC filters, or lack thereof, as the cause for legal action. A total of 672 cases were analyzed for type of case (medical malpractice or product liability), filter model implanted, filter complications, court decisions, and settlement payments if any.
Of 95 analyzed cases, 20 (21.1%) were medical malpractice cases and 75 (78.9%) were product liability cases. C.R. Bard was the manufacturer associated with the most lawsuits (n = 41, 48.8%). The most litigious filters were the G2 filter from C.R. Bard (n = 17, 20.2%) and Greenfield filter from Boston Scientific (n = 17). The most common complications were IVC penetration (n = 26, 29.9%), filter migration (n = 26, 29.9%), filter fracture (n = 23, 26.4%), and tilt (n = 16, 18.4%). The number of product liability cases has increased from accounting for 25.0% (2 of 8) of filter lawsuits between 2000 and 2010 to 83.9% (73 of 87) during 2011-2020. Of the 20 medical malpractice claims, 9 (45%) were filed for failure to place a filter. One physician was found liable for filter-related complications by a state court in 2014.
The majority of recent IVC filter-related lawsuits are filed against manufacturers on the basis of product liability claims, with the main litigious filters being the G2 and Greenfield filters. Most cases resulted in rulings for physicians or manufacturers. Some were filed against physicians for filter-related complications or for failure to place an IVC filter.
识别并分析在一个公认的法律研究数据库中公布的所有与下腔静脉(IVC)滤器相关的医疗事故和产品责任诉讼。
使用法律研究数据库LexisNexis检索提及IVC滤器造成伤害或未造成伤害作为法律诉讼原因的案例。总共对672个案例进行了分析,涉及案件类型(医疗事故或产品责任)、植入的滤器型号、滤器并发症、法院判决以及如有赔偿的和解金额。
在95个分析案例中,20个(21.1%)是医疗事故案例,75个(78.9%)是产品责任案例。C.R. Bard是涉及诉讼最多的制造商(n = 41,48.8%)。引发诉讼最多的滤器是C.R. Bard的G2滤器(n = 17,20.2%)和波士顿科学公司的Greenfield滤器(n = 17)。最常见的并发症是下腔静脉穿透(n = 26,29.9%)、滤器移位(n = 26,29.9%)、滤器断裂(n = 23,26.4%)和倾斜(n = 16,18.4%)。产品责任案例的数量已从2000年至2010年占滤器诉讼的25.0%(8个中的2个)增加到2011年至2020年期间的83.9%(87个中的73个)。在20个医疗事故索赔中,9个(45%)是因未放置滤器而提出的。2014年,一名医生被州法院判定对与滤器相关的并发症负有责任。
近期大多数与IVC滤器相关的诉讼是基于产品责任索赔对制造商提起的,主要引发诉讼的滤器是G2滤器和Greenfield滤器。大多数案件的裁决有利于医生或制造商。一些诉讼是针对医生因与滤器相关的并发症或未放置IVC滤器而提起的。